(Q38081367)

28 August 2017

TREM2 in Alzheimer's disease (English)

1 reference

28 August 2017

0 references

2

1 reference

28 August 2017

4

Lan Tan

1 reference

28 August 2017

1

Teng Jiang

1 reference

28 August 2017

Xi-Chen Zhu

3

1 reference

28 August 2017

14 February 2013

1 reference

28 August 2017

Molecular Neurobiology

1 reference

28 August 2017

48

1 reference

28 August 2017

1

1 reference

28 August 2017

180-185

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-013-8424-8

28 August 2017

0 references

cites work

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Heterogeneity of CNS myeloid cells and their roles in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Microglia and neuroinflammation: a pathological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Alzheimer disease: TREM2 linked to late-onset AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Variant TREM2 as risk factor for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

TREM2 Variants in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

TREMs in the immune system and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Regulation of innate immune responses in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Vasoactive intestinal peptide re-balances TREM-1/TREM-2 ratio in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Nasu-Hakola disease (PLOSL): report of five cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Mutations in TREM2 lead to pure early-onset dementia without bone cysts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

Cutting Edge: TREM-2 Attenuates Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8424-8

TREM2: a new risk factor for Alzheimer's disease

21 January 2018

1 reference

12 December 2020

Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia

1 reference

12 December 2020

Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement

1 reference

12 December 2020

Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration

1 reference

12 December 2020

Neuropsychological tests and functional nuclear neuroimaging provide evidence of subclinical impairment in Nasu-Hakola disease heterozygotes

1 reference

12 December 2020

10.1007/S12035-013-8424-8

Identifiers

DOI

1 reference

PubMed ID

23407992

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23407992